Women's Health
Daré Bioscience begins Phase I trial of primary dysmenorrhea therapy
Daré Bioscience has commenced a Phase I clinical trial of its development programme to treat primary dysmenorrhea by delivering diclofenac,…
Inclusive drugs: designing clinical trials for the pregnant population
The inclusion of female participants in clinical trials has been a never-ending battle for almost three decades. The historical tragedy…
US FDA grants approval for Gradalis’ Phase III ovarian cancer trial
The US Food and Drug Administration (FDA) has granted clearance to Gradalis for the Phase III VITAL-V clinical trial of…
Anixa begins Phase Ib trial of breast cancer vaccine
Anixa Biosciences has begun a Phase Ib clinical trial of its preventative breast cancer vaccine. Being carried out at the Cleveland Clinic in…
Remember the perils of breast cancer in the Awareness Month this year
Despite the advances in the diagnosis and treatment of breast cancer, this condition is still the leading cause of cancer…
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
Genelux begins Phase III ovarian cancer combination treatment trial
Genelux has commenced the Phase III clinical trial of its Olvimulogene Nanivacirepvec (Olvi-Vec), along with platinum-doublet plus bevacizumab, in platinum-resistant/refractory ovarian cancer…
GSK’s Zejula offers lasting PFS benefit in Phase III ovarian cancer trial
GSK has reported long-term findings from the Phase III PRIMA (ENGOT-OV26/GOG-3012) clinical trial where Zejula (niraparib) offered a lasting and clinically meaningful progression-free…
Dizal reports positive Phase I data for breast cancer therapy
Dizal has reported positive safety and pharmacokinetic findings from the Phase I clinical trial of DZD1516 in HER2 positive metastatic…
Pipeline Moves: Novartis completes Phase II Sjögren’s syndrome trial, advancement prospects jump
This week on Pipeline Moves, we look into the Novartis completion of a Phase II trial in Sjögren's syndrome. We…
Astellas reports Phase III data of fezolinetant for menopause-linked VMS
Astellas Pharma has reported topline findings from the Phase III MOONLIGHT 3 clinical trial of fezolinetant to treat moderate to…